The Experts below are selected from a list of 40734 Experts worldwide ranked by ideXlab platform
Michael R Tuttle - One of the best experts on this subject based on the ideXlab platform.
-
using the american thyroid association risk Stratification System to refine and individualize the american joint committee on cancer eighth edition disease specific survival estimates in differentiated thyroid cancer
Thyroid, 2018Co-Authors: Sana A Ghaznavi, Ian Ganly, Crystal English, Jonathan Wills, Michael R TuttleAbstract:Background: The eighth edition of the American Joint Committee on Cancer (AJCC) staging System has reclassified up to one third of differentiated thyroid cancer patients into one of the younger pro...
-
implementing the modified 2009 american thyroid association risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence
Thyroid, 2015Co-Authors: Fabian Pitoia, Fernando Jerkovich, Carolina Urciuoli, Angelica Schmidt, Erika Abelleira, Fernanda Bueno, Graciela Cross, Michael R TuttleAbstract:Objective: The primary purpose of this study was to validate the proposed modified 2009 American Thyroid Association Risk Stratification System (M-2009-RSS) in patients with thyroid cancer and to compare the findings with those of the 2009 ATA Risk of Recurrence (2009 ATA-RR) and the Ongoing Risk of recurrence System. The secondary purpose was to assess which risk Stratification System had the best predictive value to foresee the probability of structural incomplete response or the no evidence of disease (NED) status at the end of follow-up. Subjects and Methods: This retrospective review included 149 patients with differentiated thyroid cancer who had low and intermediate 2009 ATA-RR and were treated at a single experienced center and followed-up for a median of 6 years (range 3–12 years). Each patient was risk stratified using both the 2009 ATA-RR and the M-2009-RSS. The primary endpoints were 1) the best response to initial therapy defined as either excellent response, biochemical or structural incompl...
-
outcomes of patients with differentiated thyroid cancer risk stratified according to the american thyroid association and latin american thyroid society risk of recurrence classification Systems
Thyroid, 2013Co-Authors: Fabian Pitoia, Carolina Urciuoli, Erika Abelleira, Fernanda Bueno, Graciela Cross, Michael R TuttleAbstract:Objectives: The aims of this study were to validate the proposed Latin American Thyroid Society (LATS) risk of recurrence Stratification System and to compare the findings with those of the American Thyroid Association (ATA) risk of recurrence Stratification System. Subjects and Methods: This study is a retrospective review of papillary thyroid cancer patients treated with total thyroidectomy and radioactive iodine at a single experienced thyroid cancer center and followed according to the LATS management guidelines. Each patient was risk-stratified using both the LATS and ATA staging Systems. The primary endpoints were (i) the best response to initial therapy defined as either remission (stimulated thyroglobulin [Tg] 1 ng/mL in the absence o...
-
in differentiated thyroid cancer an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response
Thyroid, 2011Co-Authors: Fernanda Vaisman, Hernan Tala, Ravinder K Grewal, Michael R TuttleAbstract:Background: We previously demonstrated the clinical utility of using response to therapy variables obtained during the first 2 years of follow-up to actively modify initial risk estimates which were obtained using standard clinic-pathologic staging Systems. While our proposed dynamic risk Stratification System accurately reclassified patients who demonstrated an excellent response to therapy as low-risk patients, it grouped patients with either biochemical or structural evidence of disease into a single incomplete response to therapy cohort. This cohort included a wide variety of patients ranging from very minor thyroglobulin (Tg) elevations in the absence of structurally identifiable disease to widespread, progressive structural disease. Here we determined whether subdivision of the incomplete response to therapy category more precisely predicted clinical outcomes. We hypothesized that patients with an incomplete response to therapy based on persistently abnormal Tg values alone would have better clinica...
Fabian Pitoia - One of the best experts on this subject based on the ideXlab platform.
-
implementing the modified 2009 american thyroid association risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence
Thyroid, 2015Co-Authors: Fabian Pitoia, Fernando Jerkovich, Carolina Urciuoli, Angelica Schmidt, Erika Abelleira, Fernanda Bueno, Graciela Cross, Michael R TuttleAbstract:Objective: The primary purpose of this study was to validate the proposed modified 2009 American Thyroid Association Risk Stratification System (M-2009-RSS) in patients with thyroid cancer and to compare the findings with those of the 2009 ATA Risk of Recurrence (2009 ATA-RR) and the Ongoing Risk of recurrence System. The secondary purpose was to assess which risk Stratification System had the best predictive value to foresee the probability of structural incomplete response or the no evidence of disease (NED) status at the end of follow-up. Subjects and Methods: This retrospective review included 149 patients with differentiated thyroid cancer who had low and intermediate 2009 ATA-RR and were treated at a single experienced center and followed-up for a median of 6 years (range 3–12 years). Each patient was risk stratified using both the 2009 ATA-RR and the M-2009-RSS. The primary endpoints were 1) the best response to initial therapy defined as either excellent response, biochemical or structural incompl...
-
outcomes of patients with differentiated thyroid cancer risk stratified according to the american thyroid association and latin american thyroid society risk of recurrence classification Systems
Thyroid, 2013Co-Authors: Fabian Pitoia, Carolina Urciuoli, Erika Abelleira, Fernanda Bueno, Graciela Cross, Michael R TuttleAbstract:Objectives: The aims of this study were to validate the proposed Latin American Thyroid Society (LATS) risk of recurrence Stratification System and to compare the findings with those of the American Thyroid Association (ATA) risk of recurrence Stratification System. Subjects and Methods: This study is a retrospective review of papillary thyroid cancer patients treated with total thyroidectomy and radioactive iodine at a single experienced thyroid cancer center and followed according to the LATS management guidelines. Each patient was risk-stratified using both the LATS and ATA staging Systems. The primary endpoints were (i) the best response to initial therapy defined as either remission (stimulated thyroglobulin [Tg] 1 ng/mL in the absence o...
Alfonsina Chiefari - One of the best experts on this subject based on the ideXlab platform.
-
patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves the performance of the american thyroid association Stratification System
Thyroid, 2020Co-Authors: Pierpaolo Trimboli, Arnoldo Piccardo, Alberto Signore, Stefano Valabrega, Agnese Barnabei, Giuliano Santolamazza, Arianna Di Paolo, Valeria Stati, Alfonsina ChiefariAbstract:Background: The 2015 American Thyroid Association (ATA) guidelines proposed a three-category System for estimating the risk of recurrence of differentiated thyroid carcinoma (DTC). This System incl...
Alberto Signore - One of the best experts on this subject based on the ideXlab platform.
-
patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves the performance of the american thyroid association Stratification System
Thyroid, 2020Co-Authors: Pierpaolo Trimboli, Arnoldo Piccardo, Alberto Signore, Stefano Valabrega, Agnese Barnabei, Giuliano Santolamazza, Arianna Di Paolo, Valeria Stati, Alfonsina ChiefariAbstract:Background: The 2015 American Thyroid Association (ATA) guidelines proposed a three-category System for estimating the risk of recurrence of differentiated thyroid carcinoma (DTC). This System incl...
Graciela Cross - One of the best experts on this subject based on the ideXlab platform.
-
implementing the modified 2009 american thyroid association risk Stratification System in thyroid cancer patients with low and intermediate risk of recurrence
Thyroid, 2015Co-Authors: Fabian Pitoia, Fernando Jerkovich, Carolina Urciuoli, Angelica Schmidt, Erika Abelleira, Fernanda Bueno, Graciela Cross, Michael R TuttleAbstract:Objective: The primary purpose of this study was to validate the proposed modified 2009 American Thyroid Association Risk Stratification System (M-2009-RSS) in patients with thyroid cancer and to compare the findings with those of the 2009 ATA Risk of Recurrence (2009 ATA-RR) and the Ongoing Risk of recurrence System. The secondary purpose was to assess which risk Stratification System had the best predictive value to foresee the probability of structural incomplete response or the no evidence of disease (NED) status at the end of follow-up. Subjects and Methods: This retrospective review included 149 patients with differentiated thyroid cancer who had low and intermediate 2009 ATA-RR and were treated at a single experienced center and followed-up for a median of 6 years (range 3–12 years). Each patient was risk stratified using both the 2009 ATA-RR and the M-2009-RSS. The primary endpoints were 1) the best response to initial therapy defined as either excellent response, biochemical or structural incompl...
-
outcomes of patients with differentiated thyroid cancer risk stratified according to the american thyroid association and latin american thyroid society risk of recurrence classification Systems
Thyroid, 2013Co-Authors: Fabian Pitoia, Carolina Urciuoli, Erika Abelleira, Fernanda Bueno, Graciela Cross, Michael R TuttleAbstract:Objectives: The aims of this study were to validate the proposed Latin American Thyroid Society (LATS) risk of recurrence Stratification System and to compare the findings with those of the American Thyroid Association (ATA) risk of recurrence Stratification System. Subjects and Methods: This study is a retrospective review of papillary thyroid cancer patients treated with total thyroidectomy and radioactive iodine at a single experienced thyroid cancer center and followed according to the LATS management guidelines. Each patient was risk-stratified using both the LATS and ATA staging Systems. The primary endpoints were (i) the best response to initial therapy defined as either remission (stimulated thyroglobulin [Tg] 1 ng/mL in the absence o...